Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder.

Montoya A, Hervás A, Fuentes J, Cardo E, Polavieja P, Quintero J, Tannock R.

Neuropsychiatr Dis Treat. 2014 Jun 13;10:1081-92. doi: 10.2147/NDT.S62487. eCollection 2014.

2.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373
3.

Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms.

Bai GN, Wang YF, Yang L, Niu WY.

Neuropsychiatr Dis Treat. 2015 Oct 20;11:2721-35. doi: 10.2147/NDT.S88625. eCollection 2015.

4.

Health-related quality of life and functional outcomes from a randomized-withdrawal study of long-term lisdexamfetamine dimesylate treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Banaschewski T, Johnson M, Lecendreux M, Zuddas A, Adeyi B, Hodgkins P, Squires LA, Coghill DR.

CNS Drugs. 2014 Dec;28(12):1191-203. doi: 10.1007/s40263-014-0193-z.

5.
6.
8.

A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Wilens TE, Robertson B, Sikirica V, Harper L, Young JL, Bloomfield R, Lyne A, Rynkowski G, Cutler AJ.

J Am Acad Child Adolesc Psychiatry. 2015 Nov;54(11):916-25.e2. doi: 10.1016/j.jaac.2015.08.016. Epub 2015 Sep 15.

PMID:
26506582
9.

Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.

Ayaz M, Ayaz AB, Soylu N, Yüksel S.

J Child Adolesc Psychopharmacol. 2014 Oct;24(8):442-7. doi: 10.1089/cap.2014.0002. Epub 2014 Jul 10.

PMID:
25010598
10.

Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.

Dittmann RW, Schacht A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM.

J Child Adolesc Psychopharmacol. 2011 Apr;21(2):97-110. doi: 10.1089/cap.2009.0111. Epub 2011 Apr 13.

PMID:
21488751
11.
12.

A Randomized Controlled Trial Evaluating the Efficacy of a Psychoeducation Program for Families of Children and Adolescents With ADHD in the United Kingdom: Results After a 6-Month Follow-Up.

Ferrin M, Perez-Ayala V, El-Abd S, Lax-Pericall T, Jacobs B, Bilbow A, Taylor E.

J Atten Disord. 2016 Feb 2. pii: 1087054715626509. [Epub ahead of print]

PMID:
26838557
13.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
14.

Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.

Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC; MTA Cooperative Group.

J Child Psychol Psychiatry. 2017 Jun;58(6):663-678. doi: 10.1111/jcpp.12684. Epub 2017 Mar 10.

PMID:
28295312
15.

Parental attention-deficit/hyperactivity disorder predicts child and parent outcomes of parental friendship coaching treatment.

Griggs MS, Mikami AY.

J Am Acad Child Adolesc Psychiatry. 2011 Dec;50(12):1236-46. doi: 10.1016/j.jaac.2011.08.004. Epub 2011 Oct 5.

16.

Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Otasowie J, Castells X, Ehimare UP, Smith CH.

Cochrane Database Syst Rev. 2014 Sep 19;(9):CD006997. doi: 10.1002/14651858.CD006997.pub2. Review.

PMID:
25238582
17.
19.

Computer-assisted management of attention-deficit/hyperactivity disorder.

Lavigne JV, Dulcan MK, LeBailly SA, Binns HJ, Cummins TK, Jha P.

Pediatrics. 2011 Jul;128(1):e46-53. doi: 10.1542/peds.2010-2684. Epub 2011 Jun 13.

20.

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR.

CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6.

Supplemental Content

Support Center